Skip to content

The OneFlorida Cancer Control Alliance: Implementing the 6As in Pediatric Primary Care

The OneFlorida Cancer Control Alliance: Implementing the 6As in Pediatric Primary Care

Status
Terminated
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03044691
Enrollment
84
Registered
2017-02-07
Start date
2017-02-27
Completion date
2017-11-11
Last updated
2019-07-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Smoking Cessation

Brief summary

The primary purpose of our study is to conduct a pilot, practice-based intervention focused on increasing adherence to the 6As for youth ages 11 through 17 years. The 6As are: (1) Anticipate (future use), (2) Ask (about tobacco use), (3) Advise (advise the patient to quit using tobacco), (4) Assess (the patient's readiness to quit using tobacco), (5) Assist (by setting a quit date, providing materials on quitting tobacco, providing tobacco cessation medications, and referring the patient for additional services and/or counseling) , and (6) Arrange (by re-contacting the patient after their quit date and arranging a follow-up visit).

Detailed description

Investigators will incorporate American Academy of Pediatrics (AAP) best practice recommendations to screen and counsel parents. The specific aims of this study are to: (1) Develop and deploy an electronic short screening tool for tobacco and nicotine product use into pediatric primary care workflow in conjunction with clinician and office staff training on the 6As and parent screening through the use of trained Clinical Practice Facilitators, clinician-engaged adaptations of the intervention to fit their practice workflow, and support for Maintenance of Certification (MOC) to engage pediatricians in implementing the best practices; (2) Gather pilot data about the effectiveness of the intervention on clinician adherence to best practices and changes in practice capacity for change, adaptive reserve, and clinician self-efficacy; and (3) Examine the congruence between documentation of the intervention in the electronic health record (EHR) and youth report of the intervention.

Interventions

BEHAVIORALResearchACTS software

screen patients for tobacco and nicotine product use (using the anticipate and ask components of the 6As) by having youth complete a tobacco and nicotine use screening tool using the ResearchACTS software.

Sponsors

University of Florida
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
HEALTH_SERVICES_RESEARCH
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
11 Years to 17 Years
Healthy volunteers
Yes

Inclusion criteria

* 11-17 years old

Exclusion criteria

* 18 years and older

Design outcomes

Primary

MeasureTime frameDescription
Feasibility of ResearchACTS Software in Clinical Assessment of Tobacco Use MeasuresBaselineDuring the recruitment period, investigators will observe feedback from patients and clinic staff on how the feasibility of using the ResearchACTS software to capture tobacco use measures in a clinical setting. Feasibility of the software tool will be demonstrated by the ability of patients to complete the assessment within the timeframe afforded during a clinical visit.

Countries

United States

Participant flow

Participants by arm

ArmCount
Control Clinic
The control group will have to complete the Adaptive Reserve and Change Process Capability Questionnaire and Clinician Survey at baseline and 9 months. Clinicians will provide their usual care related to tobacco and nicotine product use screening and cessation recommendations. Medical record of patients will be reviewed at baseline and at 6 months.
0
Intervention Clinic
Participants will be asked to complete the Youth Tobacco and Nicotine Product Questionnaire and Parent Brief Questionnaire (PBQ) using the ResearchACTS software at the point of care. A follow-up survey Youth Tobacco and Nicotine Product Primary Care survey will be administered to participants at least 30 days after their clinic visit. ResearchACTS software: screen patients for tobacco and nicotine product use (using the anticipate and ask components of the 6As) by having youth complete a tobacco and nicotine use screening tool using the ResearchACTS software.
84
Total84

Baseline characteristics

CharacteristicTotalIntervention Clinic
Age, Categorical
<=18 years
84 Participants84 Participants
Age, Categorical
>=65 years
0 Participants0 Participants
Age, Categorical
Between 18 and 65 years
0 Participants0 Participants
Race and Ethnicity Not Collected0 Participants
Region of Enrollment
United States
84 participants84 participants
Sex: Female, Male
Female
32 Participants32 Participants
Sex: Female, Male
Male
52 Participants52 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
deaths
Total, all-cause mortality
0 / 00 / 75
other
Total, other adverse events
0 / 00 / 75
serious
Total, serious adverse events
0 / 00 / 75

Outcome results

Primary

Feasibility of ResearchACTS Software in Clinical Assessment of Tobacco Use Measures

During the recruitment period, investigators will observe feedback from patients and clinic staff on how the feasibility of using the ResearchACTS software to capture tobacco use measures in a clinical setting. Feasibility of the software tool will be demonstrated by the ability of patients to complete the assessment within the timeframe afforded during a clinical visit.

Time frame: Baseline

Population: No-one was recruited into the control clinic arm.

ArmMeasureCategoryValue (COUNT_OF_PARTICIPANTS)
Control ClinicFeasibility of ResearchACTS Software in Clinical Assessment of Tobacco Use MeasuresAble to complete0 Participants
Control ClinicFeasibility of ResearchACTS Software in Clinical Assessment of Tobacco Use MeasuresUnable to complete0 Participants
Intervention ClinicFeasibility of ResearchACTS Software in Clinical Assessment of Tobacco Use MeasuresAble to complete84 Participants
Intervention ClinicFeasibility of ResearchACTS Software in Clinical Assessment of Tobacco Use MeasuresUnable to complete0 Participants

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026